Italia markets closed

TEVA Jun 2024 20.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,07000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0700
Aperto0,0600
Denaro0,0000
Domanda1,2700
Prezzo d'esercizio20,00
Scadenza2024-06-28
Min-Max giorno0,0600 - 0,0700
Contratto - Min-MaxN/D
Volume2
Open Interest39
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.